Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03315689 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Universalis (AU)
Alopecia Totalis (AT)

Interventions

DRUG: Vehicle
DRUG: ATI-50002

Sponsor

Aclaris Therapeutics, Inc.